Literature DB >> 18724570

Piracetam in severe breath holding spells.

Matloob Azam1, Nasera Bhatti, Naheed Shahab.   

Abstract

BACKGROUND: Breath holding spells (BHS) are apparently frightening events occurring in otherwise healthy children. Generally, no medical treatment is recommended and parental reassurance is believed to be enough, however, severe BHS can be very stressful for the parents and a pharmacological agent may be desired in some of these children.
OBJECTIVE: In this prospective study aim was to determine the usefulness of piracetam as prophylactic treatment for severe BHS.
METHODS: Children were recruited from Neurology Clinic in Children's Hospital, Islamabad between January 2002 to December 2004. Diagnosis of BHS was based on characteristic history and normal physical examination. Piracetam was prescribed to those children who were diagnosed as severe BHS in a dose ranging from 50-100 mg/kg/day. Iron supplements were added if hemoglobin was less than 10 gm%. Patients were seen at 2-4 weeks interval and follow-up was continued until 3 months after the cessation of drug therapy.
RESULTS: Fifty-two children were enrolled in the study, 34 boys and 18 girls. Ages ranged from 4 weeks to 5 years with mean age of 17 months. In 81% of children, spells disappeared completely and in 9% frequency was reduced to less than one per month and of much lesser intensity. Prophylaxis was given for 3-6 months (mean 5) duration.
CONCLUSIONS: Piracetam is an effective prophylactic treatment for severe BHS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18724570     DOI: 10.2190/PM.38.2.f

Source DB:  PubMed          Journal:  Int J Psychiatry Med        ISSN: 0091-2174            Impact factor:   1.210


  7 in total

1.  Double-blind, placebo-controlled trial on the effect of piracetam on breath-holding spells.

Authors:  Happy Sawires; Osama Botrous
Journal:  Eur J Pediatr       Date:  2012-07       Impact factor: 3.183

2.  Improved quality of life after treatment of prolonged asystole during breath holding spells with a cardiac pacemaker.

Authors:  Bruno Kolterer; Roman Antonin Gebauer; Jan Janousek; Ingo Dähnert; Frank Thomas Riede; Christian Paech
Journal:  Ann Pediatr Cardiol       Date:  2015 May-Aug

3.  Drug utilization in pediatric neurology outpatient department: A prospective study at a tertiary care teaching hospital.

Authors:  Krutika M Bhatt; Supriya D Malhotra; Kamlesh P Patel; Varsha J Patel
Journal:  J Basic Clin Pharm       Date:  2014-06

Review 4.  Breath-Holding Spells in Pediatrics: A Narrative Review of the Current Evidence.

Authors:  Alexander K C Leung; Amy A M Leung; Alex H C Wong; Kam Lun Hon
Journal:  Curr Pediatr Rev       Date:  2019

5.  The Comparison of Levetiracetam and Piracetam Effectiveness on Breath-Holding Spells in Children: A Randomized Controlled Clinical Trial.

Authors:  Mohammad Reza Ghazavi; Mohammad Mehdi Salehi; Jafar Nasiri; Omid Yaghini; Vahid Mansouri; Neda Hoseini
Journal:  Adv Biomed Res       Date:  2021-12-25

6.  Effects of piracetam on pediatric breath holding spells: a randomized double blind controlled trial.

Authors:  Ali Abbaskhanian; Sara Ehteshami; Sadegh Sajjadi; Mohammad Sadegh Rezai
Journal:  Iran J Child Neurol       Date:  2012

7.  Evaluation of the Efficacy of LevetiracetamPlus Iron in Comparison With Iron Alone in Controlling and Reducing the Frequency of Breath-Holding Spells in Children Aged 6 Months to 5 Years.

Authors:  Ezatolah Abbasi; Ahad Ghazavi; Masoud Hassanvand Amouzadeh; Mohammad Valizadeh; Masoud Matinkhah
Journal:  Iran J Child Neurol       Date:  2020
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.